Andrew Spaventa - Net Worth and Insider Trading
Andrew Spaventa Net Worth
The estimated net worth of Andrew Spaventa is at least $3 Million dollars as of 2024-11-05. Andrew Spaventa is the CEO of Singular Genomics Systems Inc and owns about 140,685 shares of Singular Genomics Systems Inc (OMIC) stock worth over $3 Million. Details can be seen in Andrew Spaventa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Spaventa has not made any transactions after 2024-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Spaventa
Andrew Spaventa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Spaventa owns 1 companies in total, including Singular Genomics Systems Inc (OMIC) .
Click here to see the complete history of Andrew Spaventa’s form 4 insider trades.
Insider Ownership Summary of Andrew Spaventa
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OMIC | Singular Genomics Systems Inc | 2024-09-15 | director & 10 percent owner & Chief Executive Officer |
Andrew Spaventa Latest Holdings Summary
Andrew Spaventa currently owns a total of 1 stock. Andrew Spaventa owns 140,685 shares of Singular Genomics Systems Inc (OMIC) as of September 15, 2024, with a value of $3 Million.
Latest Holdings of Andrew Spaventa
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMIC | Singular Genomics Systems Inc | 2024-09-15 | 140,685 | 23.12 | 3,252,834 |
Holding Weightings of Andrew Spaventa
Andrew Spaventa Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Spaventa has made a total of 2 transactions in Singular Genomics Systems Inc (OMIC) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Singular Genomics Systems Inc is the sale of 175 shares on September 15, 2024, which brought Andrew Spaventa around $2,167.
Insider Trading History of Andrew Spaventa
- 1
Andrew Spaventa Trading Performance
GuruFocus tracks the stock performance after each of Andrew Spaventa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Spaventa is 25.21%. GuruFocus also compares Andrew Spaventa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Spaventa within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Spaventa's insider trading performs compared to the benchmark.
Performance of Andrew Spaventa
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.86 |  | | | | |
| Relative Return to S&P 500(%) | -7.41 | | | | | |
Andrew Spaventa Ownership Network
Ownership Network List of Andrew Spaventa
Ownership Network Relation of Andrew Spaventa
Andrew Spaventa Owned Company Details
What does Singular Genomics Systems Inc do?
Who are the key executives at Singular Genomics Systems Inc?
Andrew Spaventa is the director & 10 percent owner & Chief Executive Officer of Singular Genomics Systems Inc. Other key executives at Singular Genomics Systems Inc include Chief Scientific Officer Eli N. Glezer , Chief Operating Officer Jyotsna Ghai , and Chief Commercial Officer Sam Ropp .
Singular Genomics Systems Inc (OMIC) Insider Trades Summary
Over the past 18 months, Andrew Spaventa made 2 insider transaction in Singular Genomics Systems Inc (OMIC) with a net purchase of 118,293. Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 370,000 shares made by Eli N. Glezer , a net sale of 631,648 shares made by Kim P. Kamdar , and a net purchase of 122,416 shares made by Kevin C Tang .
In summary, during the past 3 months, insiders sold 175 shares of Singular Genomics Systems Inc (OMIC) in total and bought 122,416 shares, with a net purchase of 122,241 shares. During the past 18 months, 21,230 shares of Singular Genomics Systems Inc (OMIC) were sold and 138,698 shares were bought by its insiders, resulting in a net purchase of 117,468 shares.
Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Singular Genomics Systems Inc Insider Transactions
Andrew Spaventa Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Spaventa. You might contact Andrew Spaventa via mailing address: 10931 N. Torrey Pines Road, Suite 100, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
